arrow
A

Annie Delaunois

University of California, Berkeley
H指数:18
被引数:1,120

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Regulatory safety pharmacology & toxicology assessment studies: Measurement of the ECG and hemodynamic parameters in nonrodent species

安全性药理学与毒理学评价研究:非啮齿类物种的心电图和血流动力学参数测量

2025-09-010
PRE
Best practice considerations for nonclinical in vivo cardiovascular telemetry studies in non-rodent species: Delivering high quality QTc data to support ICH E14/S7B Q&As (vol 123, 107270, 2023)

非啮齿类动物非临床在体心血管遥测研究最佳实践考量:提供高质量QTc数据以支持ICH E14/S7B答疑(卷123,107270,2023)

2025-09-010
OAAI
Data-driven federated learning in drug discovery with knowledge distillation

基于知识蒸馏的药物发现中数据驱动的联邦学习

2025-03-050
PRE
The state of the art in secondary pharmacology and its impact on the safety of new medicines (May, 10.1038/s41573-024-00942-3, 2024)

次要药理学的最新技术及其对新药安全性的影响 (10.1038/s41573-024-00942-3,2024 5月)

2024-06-170
OA
The state of the art in secondary pharmacology and its impact on the safety of new medicines

二级药理学的最新技术及其对新药安全性的影响

2024-05-216
PRE
Discovery and Characterization of Potent, Efficacious, Orally Available Antimalarial Plasmepsin X Inhibitors and Preclinical Safety Assessment of UCB7362

有效,有效,口服可用的抗疟血浆蛋白酶X抑制剂的发现和表征以及UCB7362的临床前安全性评估

2022-10-1016
OAAI
Applying the CiPA approach to evaluate cardiac proarrhythmia risk of some antimalarials used off-label in the first wave of COVID-19
2021-04-0924
OAAI
Safety pharmacology - Current and emerging concepts
2013-12-0142
PREAI